Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • seqse
    Junior Member
    • Jan 2014
    • 2

    #1

    statistical justification of partitioning dataset for multiple analysis (EdgeR)

    Dear all,

    I'm doing analysis on allready mapped reads from sequencing data for differential expression with EdgeR. My experimental setup is as follow. I have samples from 4 different subjects. Material of each subject wast treated with 2 different treatments (and a control) for 2 timepoints.

    I want to analyse the effect of the treatments (compared to control and compared to eachother)

    In EdgeR I used following design
    model.matrix(~ subject+ Treatment + Time +Treatment : Time)

    I considered 2 strategies to analye te data:
    Estimate parameters from above mentioned design with all data (all samples) and use different contrasts to get the differential expressed genes I want.

    OR

    Use only the samples of the two treatments (eg. control vs treatment1, treatment 1 vs treatment 2) I want to compare to fit the parameters. So using only 2/3 of all data. Repeat the previous 3 times till I have compared all 3 treatments with eachother. So exctually 3 different analysis using only a subset of the data.

    I noticed that I could find considerably more significant differential expressed genes between 2 treatments with the last approach. But I wondered how correct this approach is? Will I have for example problems with multiple testing? (I control each analysis on fdr 5% with bejamin Hochberg)

    thanks in advance
    Kind regards

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Working...